ARESTIN® Effectiveness in Clinical Trials

ARESTIN® plus scaling and root planing (SRP) is more effective than SRP alone

Extensive clinical trial data demonstrate a clear benefit from active treatment with ARESTIN® plus SRP:

Locally administered periodontal antibiotic treatment

Click on any of the above topics for detailed data on ARESTIN® effectiveness in Clinical Trials.

For full safety information, click here.

Video not available

D. Fresch-Gray, DDS
Arlington, VA

View All Videos In Library »

Reduce harmful bacteria by 92% more than SRP alone—for up to 30 days

While SRP alone reduces levels of bacteria most closely linked to periodontal infection, ARESTIN® plus SRP is nearly twice as effective. Learn how ARESTIN® reduces red complex bacteria.

ARESTIN® is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. ARESTIN® may be used as part of a periodontal maintenance program, which includes good oral hygiene and SRP.

IMPORTANT SAFETY INFORMATION

ARESTIN® should not be used in any patient who has a known sensitivity to minocycline or tetracyclines. The use of drugs of the tetracycline class during tooth development may cause permanent discoloration of the teeth, and therefore should not be used in children or in pregnant or nursing women. Hypersensitivity reactions that included, but were not limited to, anaphylaxis, angioneurotic edema, urticaria, rash, swelling of the face and pruritus have been reported with the use of ARESTIN®. In clinical trials, the most frequently reported nondental treatment-emergent adverse events were headache, infection, flu syndrome and pain.

Please see Full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Contact us with questions about your account or MyArestin.com